Roth/MKM Reiterates Buy Rating on Aspen Aerogels (ASPN)

Go back to Roth/MKM Reiterates Buy Rating on Aspen Aerogels (ASPN)

B.Riley Reiterates Buy Rating on Aspen Aerogels (ASPN)

August 20, 2024 12:29 PM EDT

B.Riley analyst Christopher Souther reiterated a Buy rating and $35.00 price target on Aspen Aerogels (NYSE: ASPN).

The analyst commented: "Aspen Aerogels announced steps to enhance liquidity and better position itself for the potential DOE loan. The company closed on a $125M term loan facility and a... More

Aspen Aerogels (ASPN) PT Raised to $41 at TD Cowen

August 20, 2024 11:36 AM EDT

(Updated - August 20, 2024 11:37 AM EDT)

TD Cowen analyst Jeffrey Osborne raised the price target on Aspen Aerogels (NYSE: ASPN) to $41.00 (from $36.00) while maintaining a Buy rating.

The analyst commented: "Aspen completed financing with MidCap Financial which provides financial flexibility, removes convert... More

Aspen Aerogels (ASPN) Announces $125M Term Loan and $100M Revolving Credit Facility with MidCap Financial

August 19, 2024 4:30 PM EDT

Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that it has closed on a $125 million term loan facility and $100 million capacity asset-based revolving credit facility with MidCap Financial, a leading commercial finance company managed by Apollo Capital Management, L.P., focused on middle market transactions. The collateral structure of this agreement excludes the assets of... More